HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chung Mau Lo Selected Research

Focal Adhesion Kinase 2

4/2011Proline-rich tyrosine kinase 2 (Pyk2) promotes cell motility of hepatocellular carcinoma through induction of epithelial to mesenchymal transition.
1/2011The role of proline rich tyrosine kinase 2 (Pyk2) on cisplatin resistance in hepatocellular carcinoma.
2/2010Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.
6/2008The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chung Mau Lo Research Topics

Disease

104Hepatocellular Carcinoma (Hepatoma)
05/2022 - 03/2002
69Neoplasms (Cancer)
01/2022 - 03/2002
21Neoplasm Metastasis (Metastasis)
12/2021 - 04/2007
14Fibrosis (Cirrhosis)
12/2020 - 11/2002
13Liver Neoplasms (Liver Cancer)
12/2021 - 12/2007
12Hepatitis B
01/2017 - 06/2004
10Infections
08/2014 - 06/2004
8Reperfusion Injury
07/2021 - 09/2004
8Pathologic Constriction (Stenosis)
03/2017 - 01/2011
7Margins of Excision
02/2022 - 06/2012
7End Stage Liver Disease
01/2018 - 01/2007
7Liver Diseases (Liver Disease)
01/2017 - 10/2004
6Chronic Hepatitis B
06/2011 - 06/2004
5Ischemia
11/2020 - 01/2005
4Rupture
05/2022 - 07/2005
4Cholangiocarcinoma
02/2019 - 04/2007
4Portal Hypertension
12/2015 - 07/2004
4Thrombosis (Thrombus)
07/2015 - 07/2004
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 10/2016
3Wounds and Injuries (Trauma)
01/2022 - 01/2010
3Inflammation (Inflammations)
01/2017 - 07/2012
3Liver Failure
04/2015 - 07/2004
3Acute Liver Failure (Fulminant Hepatic Failure)
09/2014 - 12/2009
3Polyneuropathies (Polyneuropathy)
04/2013 - 11/2009
2Carcinogenesis
03/2021 - 02/2016
2Hypertrophy
01/2021 - 01/2017
2Fatty Liver
11/2020 - 12/2018
2Colorectal Neoplasms (Colorectal Cancer)
10/2019 - 07/2014
2Pancreatic Neoplasms (Pancreatic Cancer)
02/2018 - 06/2004
2Hypoalbuminemia
12/2017 - 10/2004
2Disease Progression
06/2017 - 04/2013
2Death (Near-Death Experience)
07/2016 - 04/2010
2Thrombocytopenia (Thrombopenia)
12/2015 - 10/2004
2Body Weight (Weight, Body)
12/2014 - 04/2006
2Necrosis
01/2012 - 01/2011
1Cholangitis
01/2022
1Hypoxia (Hypoxemia)
12/2021
1Chronic Hepatitis (Chronic Active Hepatitis)
01/2021
1Hepatitis
01/2021
1Pleural Effusion (Pleural Effusions)
12/2020

Drug/Important Bio-Agent (IBA)

9alpha-Fetoproteins (alpha-Fetoprotein)IBA
05/2022 - 09/2004
8Proteins (Proteins, Gene)FDA Link
10/2020 - 02/2010
6Messenger RNA (mRNA)IBA
06/2017 - 08/2006
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021 - 12/2007
4Cisplatin (Platino)FDA LinkGeneric
12/2021 - 01/2011
4Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2021 - 07/2005
4BilirubinIBA
09/2020 - 10/2004
4Fingolimod Hydrochloride (FTY720)FDA Link
01/2020 - 01/2005
4Immunoglobulins (Immunoglobulin)IBA
04/2016 - 07/2005
4Lamivudine (Epivir)FDA Link
10/2013 - 07/2005
4Focal Adhesion Kinase 2IBA
04/2011 - 06/2008
3Caspase 3 (Caspase-3)IBA
12/2021 - 02/2007
3Indicators and Reagents (Reagents)IBA
01/2019 - 10/2011
3Hemoglobins (Hemoglobin)IBA
01/2018 - 04/2014
3GranulinsIBA
06/2017 - 07/2015
3Antiviral Agents (Antivirals)IBA
04/2016 - 03/2009
2Reactive Oxygen Species (Oxygen Radicals)IBA
07/2021 - 07/2012
2Immunosuppressive Agents (Immunosuppressants)IBA
04/2019 - 04/2009
2AlbuminsIBA
01/2018 - 01/2008
2Oxygen (Dioxygen)IBA
10/2017 - 04/2014
2Biomarkers (Surrogate Marker)IBA
04/2016 - 08/2014
2MicroRNAs (MicroRNA)IBA
04/2016 - 12/2010
2Pharmaceutical PreparationsIBA
02/2016 - 09/2014
2Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2016 - 01/2007
2CytokinesIBA
08/2014 - 07/2012
2hepatitis B hyperimmune globulinIBA
10/2013 - 07/2005
2Immunologic Factors (Immunomodulators)IBA
01/2012 - 02/2007
2Focal Adhesion Protein-Tyrosine KinasesIBA
04/2011 - 02/2007
2rho-Associated KinasesIBA
02/2010 - 12/2007
2SteroidsIBA
02/2010 - 06/2004
1HydrogelsIBA
12/2021
1glutathione S-transferase alphaIBA
07/2021
1Transforming Growth Factor beta (TGF-beta)IBA
03/2021
1Complement System Proteins (Complement)IBA
03/2021
1Complement C5a (Complement 5a)IBA
03/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1pembrolizumabIBA
01/2021
1NivolumabIBA
01/2021
1IpilimumabIBA
01/2021
1Epidermal Growth Factor (EGF)IBA
01/2021
1Programmed Cell Death 1 ReceptorIBA
01/2021
1Interleukin-17 (Interleukin 17)IBA
11/2020

Therapy/Procedure

84Liver Transplantation
01/2022 - 06/2004
56Hepatectomy
05/2022 - 11/2002
25Transplantation
02/2020 - 03/2002
15Therapeutics
01/2021 - 06/2004
8Drug Therapy (Chemotherapy)
02/2022 - 06/2012
8Radiofrequency Ablation
01/2017 - 06/2010
6High-Intensity Focused Ultrasound Ablation
01/2021 - 10/2012
4Ligation
01/2021 - 12/2011
3Length of Stay
12/2020 - 01/2010
3Blood Transfusion (Blood Transfusions)
05/2018 - 06/2012
3Pancreaticoduodenectomy
12/2014 - 06/2004
2Palliative Care (Palliative Therapy)
01/2022 - 02/2008
2Operative Surgical Procedures
12/2018 - 01/2012
2Contraindications
03/2018 - 08/2013
2Stents
02/2018 - 09/2007
2Thrombectomy
06/2017 - 07/2004
2Extracorporeal Shockwave Therapy
07/2014 - 04/2013
1Laparoscopic Cholecystectomy
01/2022